These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6148869)

  • 1. Nadolol in hypertensive patients maintained on long-term hemodialysis.
    Michaels RS; Duchin KL; Akbar S; Meister J; Levin NW
    Am Heart J; 1984 Oct; 108(4 Pt 2):1091-4. PubMed ID: 6148869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol.
    Mancia G; Ferrari A; Pomidossi G; Parati G; Bertinieri G; Grassi G; Gregorini L; di Rienzo M; Zanchetti A
    Am Heart J; 1984 Oct; 108(4 Pt 2):1078-83. PubMed ID: 6148866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term experience with nadolol in treatment of hypertension and angina pectoris.
    Alexander JC; Christie MH; Vernam KA; Fand RS; Shafer WB
    Am Heart J; 1984 Oct; 108(4 Pt 2):1136-40. PubMed ID: 6148874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
    Am J Cardiol; 1983 Dec; 52(10):1230-7. PubMed ID: 6359851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL; Stern MA; Willard DA; McKinstry DN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.
    Pun KK; Yeung CK; Chan MK
    Br J Clin Pharmacol; 1985 Oct; 20(4):401-4. PubMed ID: 3907676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
    Frohlich ED; Messerli FH; Deslinski GR; Kobrin I
    Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
    Wilkinson R; Burr WA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1160-7. PubMed ID: 6148879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.
    Hornung RS; Gould BA; Kieso H; Raftery EB
    Br J Clin Pharmacol; 1982 Jul; 14(1):83-8. PubMed ID: 6125200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of nadolol by patients with renal impairment.
    Herrera J; Vukovich RA; Griffith DL
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):227S-231S. PubMed ID: 37878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
    Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Field trial with a new betablocker (Solgol)].
    Piergies A; Schimert G
    MMW Munch Med Wochenschr; 1980 Oct; 122(42):1473-6. PubMed ID: 6110182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of hypotensive effect of nadolol].
    Cybulska I; Brym E; Czerniewska E; Wołyńczyk-Niegowska J
    Pol Arch Med Wewn; 1980 Dec; 64(6):475-80. PubMed ID: 6111065
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
    Weth G; Schneider J; Rodatz H; Haubitz I
    Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nadolol and labetalol: comparative efficacy of two beta-blocking agents in glaucoma.
    Krieglstein GK; Kontić D
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):313-7. PubMed ID: 6114677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.